Information Provided By: 
Fly News Breaks for May 19, 2016
MDT, MZOR
May 19, 2016 | 08:31 EDT
After Mazor (MZOR) announced that it had made a strategic commercial agreement with Medtronic (MDT) for the deployment of its spinal products and that Medtronic had obtained the right to buy up to 15% of Mazor's outstanding shares, JMP Securities thinks that the deal validates Mazor's technology. JMP believes that the deal will be a meaningful , positive revenue catalyst for Mazor over the short-term and long-term. It keeps a $16 price target and Outperform rating on the shares.
News For MZOR;MDT From the Last 2 Days
There are no results for your query MZOR;MDT
